Press Releases Investors Overview News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts Company Info Overview Management Team Clinical Advisory Board Medical Consultants Presentations Contacts FAQ Financial Info Overview Balance Sheet Income Statement Cash Flow Financial Results Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Overview Board of Directors Board Committees Governance Documents Investor Tools Email Alerts Tear Sheet Investor Presentation Contacts RSS News Feed News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 All Releases Financial Releases Viveve to Present at H.C. Wainwright 22nd Annual Global Investment Conference Sep 3, 2020 Viveve Announces Exercise of Warrants for $3.6 Million Sep 1, 2020 Viveve Announces Positive Primary Efficacy Data from its SUI Feasibility Study and Positive Preclinical Outcomes that Support the Company’s New Sham Tip for Pivotal PURSUIT Trial Aug 25, 2020 Viveve Reports Second Quarter 2020 Financial Results and Provides Corporate Update Aug 13, 2020 Viveve to Host Conference Call on August 13, 2020 to Report Second Quarter 2020 Financial Results and Provide Corporate Update Aug 6, 2020 Viveve Announces Clearance of Viveve 2.0 System in Thailand Jul 14, 2020 Viveve Announces FDA Approval to Conduct PURSUIT Trial for Improvement of Stress Urinary Incontinence Jul 7, 2020 Viveve Medical Announces Adjournment of Annual Meeting Jun 29, 2020 Viveve Reports First Quarter 2020 Financial Results and Provides Corporate Update May 14, 2020 Viveve to Host Conference Call to Provide Corporate Update and First Quarter 2020 Financial Results on May 14, 2020 May 7, 2020 1 2 3 4 5 6 7 8 9 10 ...32
Viveve Announces Positive Primary Efficacy Data from its SUI Feasibility Study and Positive Preclinical Outcomes that Support the Company’s New Sham Tip for Pivotal PURSUIT Trial Aug 25, 2020
Viveve to Host Conference Call on August 13, 2020 to Report Second Quarter 2020 Financial Results and Provide Corporate Update Aug 6, 2020
Viveve Announces FDA Approval to Conduct PURSUIT Trial for Improvement of Stress Urinary Incontinence Jul 7, 2020
Viveve to Host Conference Call to Provide Corporate Update and First Quarter 2020 Financial Results on May 14, 2020 May 7, 2020
